Origin Therapeutics Holdings (XCNQ:ORIG) Notes Receivable : C$0.00 Mil (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Notes Receivable?

Origin Therapeutics Holdings's Notes Receivable for the quarter that ended in Jun. 2023 was C$0.00 Mil.

Origin Therapeutics Holdings's quarterly Notes Receivable declined from Dec. 2022 (C$0.05 Mil) to Mar. 2023 (C$0.00 Mil) but then stayed the same from Mar. 2023 (C$0.00 Mil) to Jun. 2023 (C$0.00 Mil).

Origin Therapeutics Holdings's annual Notes Receivable stayed the same from . 20 (C$0.00 Mil) to Sep. 2021 (C$0.00 Mil) but then increased from Sep. 2021 (C$0.00 Mil) to Sep. 2022 (C$0.05 Mil).

Origin Therapeutics Holdings Notes Receivable Historical Data

The historical data trend for Origin Therapeutics Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Notes Receivable Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Notes Receivable

0.05

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Notes Receivable	Get a 7-Day Free Trial				0.26	0.05	0.05	-	-

Origin Therapeutics Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Origin Therapeutics Holdings Notes Receivable Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.